While still largely a new phenomenon, biosimilars are here to stay-and this year will only bring more of them to market.
Bryant Furlow
Advertisement
Articles by Bryant Furlow
Advertisement
Latest Updated Articles
The State of Biosimilars in 2019Published: February 6th 2019 | Updated:
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
New drug class shows promise for geographic atrophy
2
Virtual care replaces, not adds, Medicare visits for health systems, analysis shows
3
CMS negotiates a 70% discount for Ozempic and Wegovy
4
Research uncovers ‘master switches’ that could portend Type 1 diabetes
5
